March 12, 2021 10:02 AM ESTUpdated 10:22 AM

With Kathy High on board, AskBio makes next leadership play and selects Bayer's Guru Ramamurthy as finance chief; Myles O'Neill and Melissa Barnes set to retire from Eli Lilly

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ The stars aligned to bring in Kathy High as president of therapeutics, and Brain Neurotherapy Bio founder Krystof Bankiewicz now leads its Parkinson …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With Kathy High on board, AskBio makes next leadership play and selects Bayer's Guru Ramamurthy as finance chief; Myles O'Neill and Melissa Barnes set to retire from Eli Lilly

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

Are programs with compounded GLP-1s safe for your population?

With Kathy High on board, AskBio makes next lead­er­ship play and se­lects Bay­er's Gu­ru Ra­ma­murthy as fi­nance chief; Myles O'Neill and Melis­sa Barnes set to re­tire from Eli Lil­ly

Copy Chief

Editor

Sign up to read this article for free.

With Kathy High on board, AskBio makes next leadership play and selects Bayer's Guru Ramamurthy as finance chief; Myles O'Neill and Melissa Barnes set to retire from Eli Lilly